Related Experiment Videos
Otitis media with effusion: can erythromycin reduce the need for ventilating tubes?
1University of Bergen, Haukeland University Hospital, Department of Otolaryngology/Head & Neck Surgery, Norway.
The Journal of Laryngology and Otology
|March 1, 1990
Summary
Erythromycin did not improve middle ear aeration in children with persistent otitis media with effusion (OME) compared to placebo. These findings support the standard practice of ventilation tube insertion for this condition.
Area of Science:
- Pediatrics
- Otolaryngology
- Pharmacology
Background:
- Otitis media with effusion (OME) is a frequent pediatric condition causing temporary hearing loss.
- Persistent OME often necessitates medical intervention, typically ventilation tube insertion.
Purpose of the Study:
- To investigate the efficacy of erythromycin versus placebo in treating chronic bilateral OME in children.
- To compare treatment outcomes in children who were candidates for tympanostomy tube insertion.
Main Methods:
- A double-blind, placebo-controlled study involving 147 children (1-15 years) with OME for over three months.
- Participants were randomized to receive either erythromycin or a placebo.
- Middle ear aeration was assessed after one month.
Main Results:
- Erythromycin showed no significant benefit over placebo in resolving OME; 12/69 (17.4%) in the erythromycin group achieved aeration versus 19/72 (26.4%) in the placebo group.
- No differences in outcomes were observed based on patient sex or age.
- The study suggests erythromycin is not an effective alternative to ventilation tubes for this condition.
Conclusions:
- Erythromycin treatment does not improve middle ear aeration in children with chronic OME.
- The study reinforces the established indication and timing for ventilation tube insertion in managing persistent OME.